EyePoint, Inc. Settles DOJ False Claims Act Case and Implements Comprehensive Compliance Program
EyePoint, Inc. Announces DOJ Settlement and Corporate Integr...
Sign in to continue:
EyePoint, Inc. Announces DOJ Settlement and Corporate Integr...
Key Highlights Investors Must Know Detalimogene vorapla...
TransCode Therapeutics, Inc. Announces Amendment and Restate...
Polomar Health Services, Inc. Announces Change of Independen...
Deep Fission, Inc. - Investor Update: Significant Amendment ...
Grayscale Solana Staking ETF: Detailed Analysis of U.S. Fede...
Dare Bioscience, Inc. Receives Nasdaq Delisting Notice: Key ...
Trinseo PLC 8-K Filing: Key Details for Shareholders T...
Tvardi Therapeutics, Inc. Files Form 8-K: Update on Capital ...
Lindsay Corporation Announces CFO Transition and New Compens...